CRISPR

Results: 222



#Item
51HBG1

HBG1" HBG2" Aγ" Gγ" ε" NGG

Add to Reading List

Source URL: www.editasmedicine.com

Language: English - Date: 2016-08-17 16:20:25
52Incidence of Type II CRISPR1-Cas Systems in Enterococcus Is Species-Dependent

Incidence of Type II CRISPR1-Cas Systems in Enterococcus Is Species-Dependent

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
53ALLEA  ALL European A c a d e m i e s  ALLEA Statement on

ALLEA ALL European A c a d e m i e s ALLEA Statement on

Add to Reading List

Source URL: www.allea.org

Language: English - Date: 2016-08-04 05:08:42
54ISCT NA 2016 Abstract Categories Stem Cells including but not limited to:  Hematopoietic  Mesenchymal  iPSC  Tissue specific

ISCT NA 2016 Abstract Categories Stem Cells including but not limited to:  Hematopoietic  Mesenchymal  iPSC  Tissue specific

Add to Reading List

Source URL: www.isct-na2016.com

Language: English - Date: 2016-02-19 14:43:52
55Microsoft Wordpublikacijos_tinklapiui-6.doc

Microsoft Wordpublikacijos_tinklapiui-6.doc

Add to Reading List

Source URL: www.ibt.lt

Language: English - Date: 2013-12-30 05:57:00
56Licensing Opportunity: Gene Editing via CRISPR CASCADE Complex Background: In a very brief period, the genome editing system known as CRISPR has vaulted to the forefront of genetic engineering methods and may outpace RNA

Licensing Opportunity: Gene Editing via CRISPR CASCADE Complex Background: In a very brief period, the genome editing system known as CRISPR has vaulted to the forefront of genetic engineering methods and may outpace RNA

Add to Reading List

Source URL: tto.montana.edu

Language: English - Date: 2014-12-22 16:20:40
57Staphyloccocus aureus Cas9: an alternative Cas9 for genome editing applications A.E. Friedland, A. Sousa, M. Collins, M.L. Maeder, G.G. Welstead, H. Jayaram, S. Gloskowski, D. Bumcrot Editas Medicine, Cambridge, MA 02142

Staphyloccocus aureus Cas9: an alternative Cas9 for genome editing applications A.E. Friedland, A. Sousa, M. Collins, M.L. Maeder, G.G. Welstead, H. Jayaram, S. Gloskowski, D. Bumcrot Editas Medicine, Cambridge, MA 02142

Add to Reading List

Source URL: www.editasmedicine.com

Language: English - Date: 2016-08-17 16:20:25
58IMP Vienna  IMP Research Institute of Molecular Pathology

IMP Vienna IMP Research Institute of Molecular Pathology

Add to Reading List

Source URL: www.imp.ac.at

Language: English - Date: 2016-07-20 10:32:20
59BÖLW-Info zu neuartigen Gentechnik-Verfahren wie CRISPR-Cas Was ist CRISPR-Cas und wie funktioniert dieses neuartige Gentech-Verfahren? CRISPR-Cas ist ein noch neuartiges Verfahren zur Veränderung der Erbsubstanz (DNA)

BÖLW-Info zu neuartigen Gentechnik-Verfahren wie CRISPR-Cas Was ist CRISPR-Cas und wie funktioniert dieses neuartige Gentech-Verfahren? CRISPR-Cas ist ein noch neuartiges Verfahren zur Veränderung der Erbsubstanz (DNA)

Add to Reading List

Source URL: www.boelw.de

Language: German - Date: 2016-04-21 08:03:50
    6016th EMBO | EMBL Science and Society conference EMBL ATC, Heidelberg, DE

    16th EMBO | EMBL Science and Society conference EMBL ATC, Heidelberg, DE

    Add to Reading List

    Source URL: events.embo.org

    Language: English - Date: 2016-04-06 09:26:04